Physician profile
Patrick Okolo
NPI 1003835299
$2,315.08
in general payments reported to CMS, 2019-2025
16 companies · $566 in 2025
The $566 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.94 · 2020: $174 · 2021: $549 · 2022: $244 · 2023: $704 · 2024: $45.45 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,315.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $706.80 | 2020-2025 | Overstitch Endoscopic Suturing System, Captivator II, Wallflex Duodenal |
| Cook Medical LLC | $512.85 | 2020-2023 | Hemospray |
| Olympus America INC. | $212.67 | 2022-2023 | Visiglide |
| Medtronic, INC. | $206.62 | 2021-2025 | Barrx |
| Fujifilm Healthcare Americas Corporation | $169.33 | 2025 | |
| Conmed Corporation | $132.95 | 2024-2025 | Conmed Biliary, Conmed Hemostasis |
| W. L. Gore & Associates, INC. | $125.76 | 2023 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Ambu INC. | $56.92 | 2021 | |
| Polynovo North America LLC | $44.30 | 2025 | Novosorb Btm |
| Abbvie INC. | $32.80 | 2023 | |
| Janssen Biotech, INC. | $26.24 | 2023 | Stelara |
| Pentax of America, INC. | $20.29 | 2020 | |
| Pfizer INC. | $20.03 | 2023 | |
| Qol Medical, LLC | $16.94 | 2019 | |
| Merit Medical Systems INC | $15.58 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Okolo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.